• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

It Is Time to Treat to Trough: Staying Ahead of the Curve in Biologic Testing.

作者信息

Vaughn Byron P, Cheifetz Adam S

机构信息

Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota.

Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

出版信息

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2384. doi: 10.1016/j.cgh.2015.03.031. Epub 2015 Apr 8.

DOI:10.1016/j.cgh.2015.03.031
PMID:25862986
Abstract
摘要

相似文献

1
It Is Time to Treat to Trough: Staying Ahead of the Curve in Biologic Testing.
Clin Gastroenterol Hepatol. 2015 Dec;13(13):2384. doi: 10.1016/j.cgh.2015.03.031. Epub 2015 Apr 8.
2
Heading back to the trough (levels of biologics in IBD).回归低谷（炎症性肠病中生物制剂的水平）
Clin Gastroenterol Hepatol. 2015 Mar;13(3):548-51. doi: 10.1016/j.cgh.2014.10.007. Epub 2014 Oct 13.
3
Reply: To PMID 25311382.
Clin Gastroenterol Hepatol. 2015 Dec;13(13):2384-5. doi: 10.1016/j.cgh.2015.07.028. Epub 2015 Jul 26.
4
Biologics and pregnancy: a clinician's guide to the management of IBD in pregnant women.生物制剂与妊娠：孕妇中炎症性肠病管理的临床医生指南。
Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):633-641. doi: 10.1080/17474124.2021.1876562. Epub 2021 Jan 25.
5
Precision Medicine in Inflammatory Bowel Diseases.炎症性肠病精准医学。
Clin Pharmacol Ther. 2017 Oct;102(4):623-632. doi: 10.1002/cpt.793. Epub 2017 Aug 24.
6
[Not Available].[无可用内容]
Drug Res (Stuttg). 2018 Nov;68(S 01):S15. doi: 10.1055/a-0733-0827. Epub 2018 Nov 19.
7
Anti-tumor necrosis factor agents and placental transfer: relevant clinical data for rational decision-making.抗肿瘤坏死因子药物与胎盘转运：用于合理决策的相关临床数据
Clin Gastroenterol Hepatol. 2013 Mar;11(3):293-4. doi: 10.1016/j.cgh.2012.11.030. Epub 2012 Dec 12.
8
[How long should combined therapy with biological and immunomodulatory agents be maintained in inflammatory bowel disease?].[炎症性肠病中生物制剂与免疫调节剂联合治疗应维持多长时间？]
Gastroenterol Hepatol. 2010 Jun-Jul;33(6):471-2; author reply 472-3. doi: 10.1016/j.gastrohep.2010.02.008. Epub 2010 Jun 24.
9
Biologic response modifiers: Indications, implications, and insights.生物反应调节剂：适应证、意义和见解。
J Allergy Clin Immunol. 2017 May;139(5):1445-1456. doi: 10.1016/j.jaci.2017.02.013. Epub 2017 Mar 2.
10
Medical Therapy for Inflammatory Bowel Disease.炎症性肠病的药物治疗
Surg Clin North Am. 2015 Dec;95(6):1159-82, vi. doi: 10.1016/j.suc.2015.08.004. Epub 2015 Oct 23.

引用本文的文献

1
Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients.阿达木单抗治疗药物监测在预测儿科克罗恩病患者短期黏膜愈合和组织学缓解中的潜在作用。
J Korean Med Sci. 2020 Apr 27;35(16):e114. doi: 10.3346/jkms.2020.35.e114.
2
The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.联合治疗的益处取决于克罗恩病的疾病表型和病程。
Aliment Pharmacol Ther. 2017 Jul;46(2):162-168. doi: 10.1111/apt.14125. Epub 2017 May 3.
3
Higher Adalimumab Drug Levels Are Associated with Mucosal Healing in Patients with Crohn's Disease.
阿达木单抗药物水平升高与克罗恩病患者的黏膜愈合相关。
J Crohns Colitis. 2016 May;10(5):507-9. doi: 10.1093/ecco-jcc/jjw041. Epub 2016 Feb 13.